The Effect of Cyclooxygenase-2 Expression in Uterine Carcinosarcoma on Survival
- 1 October 2015
- journal article
- research article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 25 (8) , 1415-1417
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Prognostic role of cyclooxygenase-2 in epithelial ovarian cancer: A meta-analysis of observational studiesGynecologic Oncology, 2013
- COX-2 Expression and Survival in Patients With Locally Advanced Cervical Cancer Treated With Chemoradiotherapy and CelecoxibInternational Journal of Gynecological Cancer, 2013
- Prognostic significance of cyclooxygenase‐2 in cervical cancer: A meta‐analysisInternational Journal of Cancer, 2012
- The relationship of COX–2 expression with estrogen receptor, progesterone receptor and prognostic parameters in endometrial carcinomasJournal of Obstetrics and Gynaecology Research, 2010
- COX‐2 expression in uterine carcinosarcomaActa Obstetricia et Gynecologica Scandinavica, 2010
- Cox-2 expression in ovarian malignanciesEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2009
- Co-expression of survivin, c-erbB2, and cyclooxygenase-2 (COX-2): prognostic value and survival of endometrial cancer patientsJournal of Cancer Research and Clinical Oncology, 2009
- Prognostic Features of Surgical Stage I Uterine CarcinosarcomaAmerican Journal of Surgical Pathology, 2007
- The prognostic importance of cyclooxygenase 2 and HER2 expression in epithelial ovarian cancerInternational Journal of Gynecological Cancer, 2007
- COX-2: a protein with an active role in gynecological cancersCurrent Opinion in Obstetrics and Gynecology, 2005